More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$174544674
EPS
--
P/E ratio
12
Price to sales
82.77
Dividend yield
5.295%
Beta
0.482305
Previous close
$16.01
Today's open
$16.09
Day's range
$16.01 - $16.16
52 week range
$15.78 - $17.09
CEO
--
Employees
--
Headquarters
,
Exchange
New York Stock Exchange
Shares outstanding
--
Issue type
Common Stock
Finance
Asset Management Services
Ichnos Glenmark Innovation (IGI) Announces Appointment of Mariana Cota Stirner, M.D., Ph.D., as Chief Medical Officer
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Ichnos Glenmark Innovation, Inc. (IGI), a global clinical-stage biotechnology company focused on developing Multispecific™ antibodies in oncology, today announced the appointment of Mariana (Maya) Cota Stirner, M.D., Ph.D., as Chief Medical Officer.
GlobeNewsWire • Jun 23, 2026

Income-Covered Closed-End Fund Report, May 2026
We screen ~400 closed-end funds for full distribution coverage, prioritizing funds with coverage above 100% to reduce risk of distribution cuts. Top Income-Covered CEFs trading at wide discounts, like BGX and VFL, offer both high yields and potential for price appreciation if discounts narrow. Funds with the most negative z-scores, such as JHI and FMY, are trading below their historical average discounts, highlighting potential value opportunities.
Seeking Alpha • Jun 12, 2026

Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors
Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a 1st-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors
GlobeNewsWire • May 20, 2026

CEF Market Weekly Review: The Key Factors Driving NII
We review the CEF market valuation and performance through the fourth week of April and highlight recent market action. CEF markets faced renewed risk aversion, with sector discounts widening to historical averages and MLPs and Convertibles led to the upside. Western Asset CEFs' NII remained largely stable; key drivers include short-term rate direction, liability management, and overdistribution.
Seeking Alpha • May 4, 2026

Western Asset Investment Grade Opportunity Trust Inc. Announces Results of Annual Meeting of Stockholders
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.
Business Wire • Apr 29, 2026

Western Asset Investment Grade Opportunity Trust Inc. Announces Financial Position as of February 28, 2026
NEW YORK--(BUSINESS WIRE)--Category: Financials.
Business Wire • Apr 22, 2026

Income-Covered Closed-End Fund Report, March 2026
The Income-Covered Closed-End Fund Report screens for CEFs with distribution coverage exceeding 100%, targeting funds less likely to cut payouts. Discounted, fully-covered CEFs offer dual benefits: potential price appreciation from narrowing discounts and enhanced yields based on full NAV distributions. Composite metrics combining yield, discount, and z-score help identify CEFs offering value on both absolute and relative terms, with high income potential.
Seeking Alpha • Apr 1, 2026

Western Asset Investment Grade Opportunity Trust Inc. Announces Financial Position as of August 31, 2025
NEW YORK--(BUSINESS WIRE)--Category: Financials.
Business Wire • Oct 27, 2025

Western Asset Investment Grade Opportunity Trust Inc. (NYSE: IGI) Announces Portfolio Management Team Update
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.
Business Wire • Aug 19, 2025

Western Asset Investment Grade Opportunity Trust Inc. Announces Financial Position as of February 28, 2025
NEW YORK--(BUSINESS WIRE)--Category: Financials.
Business Wire • Apr 16, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Western Asset Investment Grade Opportunity Trust Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.